GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs.
Publication
, Journal Article
McGuire, DK; Pagidipati, NJ
Published in: Lancet Diabetes Endocrinol
October 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet Diabetes Endocrinol
DOI
EISSN
2213-8595
Publication Date
October 2021
Volume
9
Issue
10
Start / End Page
640 / 641
Location
England
Related Subject Headings
- Sodium-Glucose Transporter 2 Inhibitors
- Hypoglycemic Agents
- Humans
- Glucagon-Like Peptide-1 Receptor
- Cardiovascular Agents
- 3205 Medical biochemistry and metabolomics
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
McGuire, D. K., & Pagidipati, N. J. (2021). GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs. Lancet Diabetes Endocrinol, 9(10), 640–641. https://doi.org/10.1016/S2213-8587(21)00212-6
McGuire, Darren K., and Neha J. Pagidipati. “GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs.” Lancet Diabetes Endocrinol 9, no. 10 (October 2021): 640–41. https://doi.org/10.1016/S2213-8587(21)00212-6.
McGuire DK, Pagidipati NJ. GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs. Lancet Diabetes Endocrinol. 2021 Oct;9(10):640–1.
McGuire, Darren K., and Neha J. Pagidipati. “GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs.” Lancet Diabetes Endocrinol, vol. 9, no. 10, Oct. 2021, pp. 640–41. Pubmed, doi:10.1016/S2213-8587(21)00212-6.
McGuire DK, Pagidipati NJ. GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs. Lancet Diabetes Endocrinol. 2021 Oct;9(10):640–641.
Published In
Lancet Diabetes Endocrinol
DOI
EISSN
2213-8595
Publication Date
October 2021
Volume
9
Issue
10
Start / End Page
640 / 641
Location
England
Related Subject Headings
- Sodium-Glucose Transporter 2 Inhibitors
- Hypoglycemic Agents
- Humans
- Glucagon-Like Peptide-1 Receptor
- Cardiovascular Agents
- 3205 Medical biochemistry and metabolomics
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics